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Abstract
A single internal ribosomal entry site (IRES) in conjunction with IRES transactivating factors (ITAFs) is sufficient to recruit the
translational machinery to a eukaryotic mRNA independent of the cap structure. However, we demonstrate that the mouse
TrkB mRNA contains two independent IRESes. The mouse TrkB mRNA consists of one of two 59 leaders (1428 nt and 448 nt),
both of which include the common 39 exon (Ex2, 344 nt). Dicistronic RNA transfections and in vitro translation of
monocistronic RNA demonstrated that both full-length 59 leaders, as well as Ex2, exhibit IRES activity indicating the IRES is
located within Ex2. Additional analysis of the upstream sequences demonstrated that the first 260 nt of exon 1 (Ex1a) also
contains an IRES. Dicistronic RNA transfections into SH-SY5Y cells showed the Ex1a IRES is constitutively active. However, the
Ex2 IRES is only active in response to retinoic acid induced neural differentiation, a state which correlates with the synthesis
of the ITAF polypyrimidine tract binding protein (PTB1). Correspondingly, addition or knock-down of PTB1 altered Ex2, but
not Ex1a IRES activity in vitro and ex vivo, respectively. These results demonstrate that the two functionally independent
IRESes within the mouse TrkB 59 leader are differentially regulated, in part by PTB1.
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Introduction
In eukaryotes, recruitment of canonical factors including the
ribosome to the 7-methyl guanosine cap structure on the 59 end of
the mRNA is thought to be the primary mechanism by which
translation initiation occurs[1]. Once recruited to the mRNA, the
40S ribosome scans along the 59 leader until it encounters the
initiator codon [1]. However, initiation of a number of eukaryotic
mRNAs can also occur through internal ribosomal entry sites
(IRESes, for review see [2]), a mechanism first identified in viral
RNAs [3]. In a manner analogous to the cap structure, a single
IRES recruits the 40S ribosomal subunit to the mRNA for
translation [4,5].
Unlike initiation from the cap structure, the subset of proteins
required for initiation from a eukaryotic IRES has yet to be
determined. However, the current literature suggests that most
eukaryotic IRESes require non-canonical translation factors
referred to as IRES transactivating factors (ITAFs) for initiation.
The three isoforms of polypyrimidine tract binding protein (PTB1,
2 and 4) [6] [7], La protein[8], and upstream of n-ras protein (unr)
[9] are examples of ITAFs required for efficient translation from
eukaryotic and viral IRESes. These proteins may function as
chaperones, altering or maintaining specific RNA structures that
permit binding of the translational machinery (for review see [10]).
This theory is supported by work from the Niepmann lab
demonstrating that binding of PTB to the foot-and-mouth disease
(FMDV) IRES enhances the recruitment of the initiation factor
eIF4G and stimulates FMDV IRES activity [11]. Additionally, it
has been shown that the eukaryotic Apaf-1 59 leader undergoes
secondary structure changes upon the binding of unr and PTB,
allowing for internal initiation of translation [5].
Utilization of eukaryotic IRESes often occurs during cellular
events that reduce cap-dependent translation. For example, during
mitosis the family of eIF4E binding proteins (4E-BP) is hypopho-
sphorylated, which enhances their ability to bind eIF4E [12]. The
sequestering of eIF4E inhibits cap-dependent translation [3] and
the overall level of protein synthesis is decreased [13]. However,
during mitosis several mRNAs, including those encoding for
ornithine decarboxylase (ODC) [12] and p58 (PITSLRE kinase)
[14], are translated in an IRES-dependent manner. For PITSLRE
kinase, its IRES activity partially depends on the upregulation of
unr expression at the G2/M junction underscoring not only the
importance of the cell state, but also the importance of ITAF
availability for internal initiation.
Studies in model systems indicate that neural activity may also
promote dependency on internal initiation of translation. In
response to activity-dependent neural plasticity, Aplysia neuroen-
docrine cells undergo a switch from cap-dependent to cap-
independent translation [15]. Additionally, multiple dendritically
localized mRNAs exhibit IRES activity within neural cell lines
[16] and primary neuronal cultures [17] suggesting they may be
translated in response to neural activity.
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dendritically-localized [18] and encodes for a tyrosine kinase
receptor that binds brain-derived neurotrophin factor (BDNF) (for
review see [19]). The TrkB receptor is synthesized under diverse
conditions and its activity contributes to multiple cellular processes
(for review see [20]). In neural stem cells, the TrkB mediated
pathway promotes cell proliferation [21]. In the adult, TrkB
activity contributes to changes in synaptic efficacy and local
connectivity, ultimately affecting learning and memory (for review
see [19]). Owing to its diverse functions, TrkB expression is
regulated at multiple steps in response to various cellular
conditions [22,23,24]. For example, ischemia stimulates TrkB
protein synthesis in order to promote cell survival [25].
Interestingly, ischemia also inhibits cap-dependent translation
[26] suggesting that the upregulation of TrkB occurs in a cap-
independent manner. In accordance with this observation, our lab
has demonstrated that the 59 leader of the mRNA encoding for
human TrkB contains an IRES [16].
We hypothesized that if IRES-dependent translation was a
critical mechanism for the synthesis of TrkB protein, then both the
presence of an IRES and its mechanism would be evolutionarily
conserved. The human TrkB 59 leader is derived from alternative
transcriptional start sites and alternative splicing of five exons [27].
Interestingly, the IRES was localized to exon 5, which is present in
all 59 leader variants [16]. Unlike the human 59 leader, the mouse
TrkB 59 leader is transcribed from two promoters and is comprised
of two exons [28]. However, similar to the human TrkB 59 leader,
all of the mouse TrkB 59 leaders contain a 39 common exon, exon
2. The human exon 5 and the mouse exon 2 sequences share a
63% identity with regions of high similarity on the extreme ends of
the exons. Consequently, we predicted that the mouse TrkB 59
leader would mediate internal initiation and that the IRES would
be located within Exon 2.
In the present report we establish that the mouse TrkB Exon 2
does contain an IRES. But surprisingly, an IRES is also located
within Exon 1 demonstrating the presence of two IRESes initiating
translation of the same open reading frame. The two IRESes are
differentially utilized based on the differentiation state of a
neuronal cell line. This phenomenon is explained in part by the
observation that PTB1 differentially affects translation mediated
by the two IRESes, despite the fact that PTB1 binds both IRESes
with similar affinity.
Results
The Mouse TrkB 59 Leaders Contain a Potential IRES
Element
To determine if the full-length 59 leaders generated from the
first promoter, Leader 1 (L1, 1.428 kb), from the second promoter,
Leader 2 (L2, 448 nt), and Exon 2 (Ex2, 344 nt) exhibited IRES
activity, they were inserted into the intercistronic region of the
dicistronic luciferase DNA vector pRF (Fig 1a and 1b)[29]. The 59
leader of the human b-globin mRNA (50 nt) and the leader of the
encephlomyocarditis virus (EMCV) (608 nt) were also inserted as
negative and positive controls, respectively [30]. The individual
constructs were transfected into two neural cell lines, C6 and N2a,
and after 24 hours the cells were harvested and assayed for
luciferase activity. A ratio of the Photinus luciferase to the Renilla
luciferase was calculated following a luciferase assay of the cell
lysates. The ratio obtained for the negative control, b-globin, was
set to one, and the ratios obtained from the other constructs were
normalized to that value.
As expected, the positive control EMCV exhibited an increased
Photinus:Renilla (P:R) luciferase ratio when compared to the b-
globin 59 leader in both cell lines. EMCV generated a ratio of 28
in C6 cells and 16 in N2a cells (Fig 2). All three mouse TrkB 59
Figure 1. The mouse TrkB 59 leaders. (A) Schematic representation of the gene structure of the mouse TrkB 59 leader [28] and variations used for
luciferase assays (B) as well as the two controls, the b-globin 59 leader and EMCV IRES. The boxes represent exons, lines represent introns, and the
blue arrows indicate the transcriptional start site of the two promoters.
doi:10.1371/journal.pone.0003242.g001
Two IRESes in the TrkB mRNA
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Ex2 exhibited a P:R ratio of 9 in C6 cells and 15 in N2a cells,
while the full-length L2 had a ratio of 7 in both cell lines.
Interestingly, L1 yielded a ratio ranging from 200–300 in the cell
lines. These results suggest that all three mouse TrkB 59 leaders
can internally initiate translation, however the presence of other
regulatory elements could also lead to an increased P:R ratio from
the DNA construct.
A Cryptic Promoter is Present in the Mouse TrkB 59
Leader
The dicistronic DNA construct has been used as the major assay
to test for IRES activity. However, additional mechanisms can
account for translation of the second cistron. The dicistronic DNA
construct used in these assays contains an intron upstream of the
Renilla luciferase gene to increase transcription and translation
efficiency. However, the presence of a cryptic splice site located in
the 59 leader of interest would lead to the splicing of the Renilla
luciferase gene, leaving only the Photinus luciferase gene to be
translated and effectively increasing the P:R ratio. In addition, the
presence of a cryptic promoter in the 59 leader would generate a
monocistronic mRNA encoding only the Photinus luciferase gene.
This process would create an mRNA consisting only of the Photinus
luciferase gene and again, would lead to an increase in the P:R ratio.
To determine if a cryptic promoter is present in the TrkB 59
leaders, we inserted the TrkB and the b-globin 59 leaders into the
intercistronic region of a promoterless dicistronic luciferase
construct (a generous gift from Dr. Anne Willis [31]). Transfection
of the promoterless dicistronic DNA into C6 cells yielded robust
Photinus luciferase activity from the TrkB L1 59 leader (Fig. 3); the
P:R ratio was 76 fold higher than that obtained from the
dicistronic construct containing the b-globin 59 leader. In addition,
both Ex2 and L2 showed a ten-fold increase in the P:R ratio. It
was perhaps surprising that L2 and Ex2 exhibited cryptic
promoter activity because a Northern blot analysis did not reveal
additional RNA species (data not shown), although this incongru-
ity has been observed previously [32]. These results indicate that
all three TrkB 59 leaders exhibit some level of cryptic promoter
activity.
The Mouse TrkB 59 Leader Internally Initiates Translation
from Dicistronic RNA
To overcome the limitations of cryptic promoter activity (and
cryptic splicing which we did not examine), we in vitro transcribed
the dicistronic DNA. The resulting dicistronic mRNA was
transfected into C6 cells. All three TrkB 59 leaders exhibited a
P:R ratio higher than that observed from the dicistronic mRNA
containing the b-globin 59 leader (Fig. 4). The largest ratio of
Figure 2. The mouse TrkB 59 leaders exhibit an increased
Photinus to Renilla luciferase (P:R) ratio. Dicistronic luciferase
constructs containing the b-globin, EMCV, and TrkB 59 leaders were
transfected into the C6 and N2a neural cell lines. The P:R ratio from each
construct was normalized to that obtained from the b-globin construct,
whose P:R ratio was set to one.
doi:10.1371/journal.pone.0003242.g002
Figure 3. The mouse TrkB 59 leaders exhibit cryptic promoter
activity. Promoterless dicistronic luciferase constructs containing the
b-globin or the TrkB 59 leaders were transfected into C6 cells. The P:R
ratio was normalized to that obtained from construct containing the b-
globin 59 leader.
doi:10.1371/journal.pone.0003242.g003
Two IRESes in the TrkB mRNA
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four, and L1 showed the lowest ratio of approximately 2.5. This
result demonstrates that all three mouse TrkB 59 leaders can
mediate IRES-dependent translation. The result also indicates that
the presence of a cryptic promoter in a 59 leader does not preclude
its ability to internally initiate translation.
Mouse TrkB 59 Leaders Initiate Translation When Cap-
Dependent Translation is Inhibited
With a capped monocistronic RNA, it cannot be determined
whether translation initiation is occurring in a cap-dependent
manner or through an IRES. To dissociate between the two
mechanisms, cap-dependent translation was inhibited ex vivo.W e
inserted the 59 leaders upstream of the Photinus luciferase gene.
The Renilla luciferase gene was contained on the same plasmid
(pRM) under an independent promoter and served as an internal
transfection control (Fig 1b). The multiple cloning site from the
pGL3 plasmid (83 nt) was used as a negative control in this
experiment because the Renilla gene on the pRM plasmid also
utilizes this multiple cloning site as its 59 leader. We have
previously shown that the pGL3 multiple cloning site does not
contain an IRES and exhibits a P:R ratio equivalent to that
obtained from a dicistronic DNA construct containing the b-
globin 59 leader [16]. The mouse TrkB and pGL3 DNA constructs
were co-transfected into C6 cells with either a hypophosphorylated
form of 4EBP [33] or a null vector. When expressed, the
hypophosphorylated 4EBP sequesters eIF4E, inhibiting cap-
dependent translation [34]. The percentage of luciferase activity
remaining in the presence of the hypophosphorylated form of
4EBP when compared to that observed in the presence of the null
vector was calculated. Translation of Renilla luciferase mRNA
containing the pGL3 multiple cloning site served as the internal
control to monitor cap-dependent translation.
In the presence of hypophosphorylated 4EBP, the Renilla
luciferase activity decreased to approximately 23–30% of the
control level for all of the constructs. This result demonstrated that
cap-dependent translation was being inhibited (Fig 5a). In
addition, the level of Photinus luciferase activity generated from
the mRNA containing the multiple cloning site from the vector
pGL3 decreased to 28% of the control confirming that its
translation was also cap-dependent. On the other hand, the
Photinus luciferase mRNA containing the EMCV IRES decreased
to 51% of the control transfection when cap-dependent translation
was inhibited confirming that it does initiate translation through a
cap-independent mechanism. The relatively large decrease in the
overall level of translation from the mRNA containing the EMCV
IRES when cap-dependent translation is shut down is believed to
be due to the addition of a cap structure to the mRNA. This
creates an artificial context for the EMCV 59 leader and when
uninhibited, allows for the cap structure to compete with the IRES
for translational machinery. All three mRNAs containing the
different mouse TrkB 59 leaders showed a smaller reduction in
activity compared to that observed from the pGL3 mRNA. Ex2
and L2 exhibited similar reductions of approximately 50%. L1
exhibited only a 15% decrease in Photinus luciferase activity in the
presence of hypophosphorylated 4EBP. This result supports the
conclusion that all three TrkB 59 leaders can initiate translation
independent of the cap. It also suggests that the contribution of
cap- and IRES-dependent translation may vary for each leader.
To further demonstrate the ability of the TrkB 59 leaders to
initiate cap-independent translation, in vitro transcribed mRNA
containing the three mouse TrkB 59 leaders or the b-globin 59
leader upstream of the Photinus luciferase open reading frame was
translated in rabbit reticulocyte lysate (RRL). Increasing concen-
trations of cap analog, which binds and sequesters eIF4E
inhibiting cap-dependent translation, was added to the lysate.
Indeed, the level of Photinus luciferase activity derived from the
mRNA containing the b-globin 59 leader was inversely propor-
tional to the concentration of cap analog (Fig 5b). However, the
level of translation from the mRNAs containing the mouse TrkB
59 leaders was relatively stable irrespective of the cap analog
concentration. These results demonstrate that the mRNA
containing the TrkB 59 leader can be translated in a cap-
independent manner.
The Mouse TrkB 59 Leader Contains Multiple Contains
Multiple IRESes
Our results indicate that an IRES element is located within
exon 2, which is present in both mouse TrkB 59 leaders. To
determine whether the unique upstream regions in each 59 leader
can also internally initiate translation, these regions were inserted
into dicistronic RNA constructs and transfected into C6 cells. The
unique region from Leader 2, L2U (104 nt, Fig 1a), generated a
P:R ratio similar to that observed with the negative control b-
globin (Fig 6a). However, the upstream sequence from Leader 1,
Ex1 (1.084 kb), generated a P:R ratio comparable to that observed
from Ex2 indicating that Ex1 contains an IRES.
To confirm the ex vivo results, we inserted Ex1 and Pr2U into
monocistronic Photinus constructs and in vitro translated the mRNA
Figure 4. The mouse TrkB 59 leaders exhibit IRES activity when
expressed in dicistronic RNA constructs. Dicistronic luciferase
mRNA containing the b-globin and the TrkB 59 leaders were transfected
into C6 cells. The P:R ratio for each construct was normalized to that of
the negative control, b-globin.
doi:10.1371/journal.pone.0003242.g004
Two IRESes in the TrkB mRNA
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decreased in the presence of increasing amounts of cap analog
similar to that observed from the mRNA containing the b-globin
59 leader. On the other hand, translation from the Ex1 construct
remained relatively constant. Taken together, the ex vivo and in vitro
data demonstrate the ability of Ex1, in addition to Ex2, to
internally initiate translation.
Exon 1 of mouse TrkB can be alternatively spliced at three sites
creating three different leaders, which all contain the first 259 nt of
the exon (Fig 1a). To identify the region within Exon 1 that
contains the IRES we created dicistronic constructs containing the
individual segments, Ex1a, Ex1b, and Ex1c, or in contiguous
pairs, Ex1ab and Ex1bc. Transfection of C6 cells with the
dicistronic RNA showed that all 59 leaders containing Ex1a
generated a P:R ratio higher than b-globin (Fig 7). However,
Ex1b, Ex1c, and Ex1bc exhibited a P:R ratio equivalent to that
obtained from b-globin. These results indicate that the IRES
element in Ex1 is located within Ex1a.
Figure 5. The mouse TrkB 59 leaders are able to initiate
translation when cap-dependent translation is inhibited. A) A
dual monocistronic construct containing the pGL3 multiple cloning site
upstream of the Renilla luciferase and the pGL3 multiple cloning site,
EMCV, or the TrkB 59 leaders upstream of the Photinus luciferase gene
was co-transfected into C6 cells with a construct encoding for a
hypophosphorylated 4EBP construct or a null vector. The level of
Photinus luciferase activity from each mRNA, when co-transfected with
the null vector, was normalized to 100 percent. The Renilla and Photinus
luciferase activity obtained in cells co-transfected with hypopho-
sphorylated 4EBP is represented as a percentage of the activity
obtained in cells co-transfected with the null plasmid. B) Monocistronic
Photinus luciferase mRNA containing the b-globin or TrkB 59 leaders was
in vitro translated in rabbit reticulocyte lysate in the presence of
increasing concentrations of cap analog. Photinus luciferase activity for
each mRNA in the absence of cap analog was set to 100 percent.
doi:10.1371/journal.pone.0003242.g005
Figure 6. The mouse TrkB mRNA contains two independent
IRESes. A) The additional sequence upstream of Exon 2 from both full-
length leaders (Ex1 and L2U) and Exon 2 alone (see Fig 1a) were
individually inserted into dicistronic RNA vectors and transfected into
C6 cells. The resulting P:R ratios were normalized to the ratio observed
from the mRNA containing the b-globin 59 leader. B) The unique
regions of the full-length TrkB 59 leaders, as well as the b-globin 59
leader were inserted upstream of a monocistronic Photinus luciferase
open reading frame and in vitro translated in the presence of increasing
concentrations of cap analog. The initial level of Photinus luciferase
activity was set to 100 percent for each mRNA.
doi:10.1371/journal.pone.0003242.g006
Two IRESes in the TrkB mRNA
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PTB activates or enhances IRES activity from a number of
cellular mRNAs [6,9,35]. As mentioned previously, unr and PTB
bind to the Apaf-1 IRES, inducing conformational changes and
allowing for internal initiation to occur [5]. PTB binds to the Apaf-1
IRES at two polypyrimidine tracts located 74 and 118 nucleotides
from the initiator codon, respectively. Sequence comparison
revealed that the mouse TrkB 59 leader has two polypyrimidine
tractsinsimilarlocationsof75and124nucleotidesfromtheinitiaton
codon suggesting that PTB may also influence RNA secondary
structure, and ultimately the IRES activity, of the mouse TrkB 59
leader. To determine the ability of PTB1 to directly bind the Ex1a
and Ex2 IRESes, we performed a filter binding assay. The cricket
paralysis virus (CrPV) IRES was used as a negative control since it
has been established that the CrPV IRES does not require protein
factors to initiate translation [36]. Radiolabeled RNA consisting of
Ex1a, Ex2, or CrPV was incubated in the presence of increasing
amounts of recombinant PTB1 protein and passed through a dot
blot apparatus. The resulting binding curve was fit using the
Langmuir equation. As expected, the CrPV IRES did not bind to
PTB1 with a significant affinity (Fig 8). However, Ex1a and Ex2
bound to PTB1 with Kd values equaling 85 nM and 46 nM,
respectively. Although PTB1 binding to both IRESes falls within the
same order of magnitude, the two-fold difference may reflect a
biologically significant difference.
The Two TrkB IRESes Are Differentially Regulated
To address whether the binding of PTB1 plays an important
role in Ex1a and Ex2 IRES activity, dicistronic RNA was in vitro
translated in the presence of 0.4 mg of PTB1 protein isoform [37].
Somewhat surprisingly, no change in the P:R ratio from Ex1a was
observed when PTB1 was present despite the ability of PTB1 to
bind to Ex1a (Fig 9a). Conversely, the P:R ratio from the
dicistronic mRNA containing Ex2 increased by 40% in the
presence of PTB1. This result suggests that PTB1 stimulates Ex2
IRES activity and that PTB1 interacts with the mouse TrkB
IRESes differently.
Changes in cell state, such as mitosis [12], inhibit cap-
dependent translation and promote ITAF synthesis and IRES
activity. Since the TrkB receptor contributes to different cellular
functions in neural stem cells and neurons, we were interested in
determining whether differentiation also affected IRES activity.
To examine the effects of differentiation on the TrkB IRESes, we
chose SH-SY5Y cells, a neuroblastoma that generates a differen-
tiated neuronal phenotype when exposed to retinoic acid [9].
Dicistronic RNA containing Ex1a, Ex2, or the b-globin 59 leader
was transfected into SH-SY5Y cells that were either treated with
DMSO (undifferentiated) or retinoic acid (differentiated) for four
days (Fig. 9b). The dicistronic mRNA containing Ex1a exhibited a
P:R ratio approximately three-fold higher than b-globin in both
the undifferentiated and differentiated cells. Surprisingly, in
undifferentiated cells Ex2 did not demonstrate IRES activity,
yielding a P:R ratio similar to that of b-globin. However, in the
differentiated cells the P:R ratio of Ex2 increased to approximately
two and a half fold that of b-globin. This result suggests that the
Ex1a IRES is constitutively active is SH-SY5Y cells, while the Ex2
IRES is only active in differentiated SH-SY5Y cells.
The ability of Ex2 to internally initiate translation in
differentiated but not undifferentiated SH-SY5Y cells indicates
the presence of a factor that is induced upon differentiation. Since
we have already established that PTB1 affects the IRES activity
from the mouse TrkB IRESes differentially, it suggests that PTB1
Figure 7. The upstream IRES in the mouse TrkB 59 leader is
located within Ex1a. The exon 1 splice variants (shown in the
schematic, see also Fig 1A) were inserted into dicistronic RNA vectors
and transfected into C6 cells. The resulting P:R ratios were normalized
to the ratio observed from b-globin 59 leader.
doi:10.1371/journal.pone.0003242.g007
Figure 8. The mouse TrkB 59 leaders bind PTB1 protein. Purified
PTB1 was added in increasing amounts to radiolabeled RNA containing
Ex1a, Ex2, or the negative control CrPV IRES. A Langmuir plot was
created using the calculated fraction bound. Disassociation constants of
85 nM and 46 nM were determined for the PTB1 interaction with Ex1a
and Ex2, respectively.
doi:10.1371/journal.pone.0003242.g008
Two IRESes in the TrkB mRNA
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observed in the SH-SY5Y cells. Indeed, differentiation of SH-
SY5Y cells by retinoic acid leads to the induction of PTB1 [9], but
not the neural isoform, nPTB (data not shown). To investigate
whether the presence of PTB1 affects TrkB IRES activity, PTB1
protein was knocked down in differentiated SH-SY5Y cells using
siRNA. Western blot analysis revealed that the siRNA reduced
PTB1 expression level by greater than 80% from that observed in
untreated differentiated cells (Fig. 10a). Additionally, transfection of
dicistronic RNA into the PTB1 depleted differentiated SH-SY5Y
cellsshowedadecreaseinEx2IRESactivity,suggestingthatPTB1is
required for internal initiation from the Ex2 IRES (Fig. 10b). The
Ex1a IRES activity was not affected by the reduction in PTB1,
confirming the differential regulation seen above.
Discussion
In the present report, we demonstrate that the mouse TrkB 59
leader contains two IRESes. One IRES is located within Ex2, a
region similar to the region within the human TrkB 59 leader
found to exhibit IRES activity [16]. The other IRES is unique to
the mouse TrkB 59 leader and is found in the 59 end of Exon 1.
Moreover, we found that the two IRESes exhibit different
characteristics. The IRES in Ex2 is active in differentiated SH-
SY5Y cells, binds PTB1, and its activity is enhanced in the
presence of PTB1. On the other hand, the IRES within Ex1a is
active in both differentiated and undifferentiated SH-SY5Y cells,
binds PTB1, but its activity is unaffected in the presence of PTB1.
Figure 9. PTB increases IRES activity from the Ex2 IRES, but
does not affect Ex1a IRES activity. A) Dicistronic luciferase mRNA
containing the Ex1a, Ex2, or b-globin 59 leader was in vitro translated in
RRL that was either untreated or supplemented with 0.4 mg of PTB1.
The change in the P:R ratio for the samples when in the presence of
PTB1 relative to the untreated sample are shown. B) The two mouse
TrkB IRESes demonstrate differential regulation. SH-SY5Y cells treated
with 2 mM retinoic acid or with DMSO (mock) for four days were
transfected with dicistronic mRNA containing the b-globin, Ex2, or Ex1a
59 leaders. The P:R ratios were normalized to that from the mRNA
containing the b-globin 59 leader.
doi:10.1371/journal.pone.0003242.g009
Figure 10. PTB expression is required for IRES activity
mediated by Ex2. A) Western blot analysis of PTB and GAPDH (as a
loading control) from lysates obtained from differentiated and
undifferentiated SH-SY5Y cells transfected with siRNA directed against
PTB or mock transfected for 72 hours. B) Dicistronic RNA containing the
two mouse TrkB IRESes were transfected into differentiated SH-SY5Y
cells depleted of PTB1 by siRNA. The P:R ratios were normalized to that
from the mRNA containing the b-globin 59 leader in control
undifferentiated SH-SY5Y cells.
doi:10.1371/journal.pone.0003242.g010
Two IRESes in the TrkB mRNA
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indicating that 59 leaders can contain both a cryptic promoter, as
well as an IRES.
Limitations of Using Dicistronic DNA Constructs to
Demonstrate IRES Activity
Historically, dicistronic constructs have been used to examine 59
leaders for the ability to internally initiate translation. However,
the increased P:R ratios that have been interpreted as the presence
of an IRES can also be due to the presence of cryptic splice sites or
cryptic promoters [32]. Removal of the promoter and intron from
the dicistronic construct demonstrated that all three TrkB 59
leaders exhibit some level of cryptic promoter activity. This result
does not rule out the possibility that cryptic splicing occurs in the
original dicistronic vector, and therefore, it is still possible that
both processing events can occur and contribute to the second
RNA species.
Our results indicate that the presence of a cryptic promoter in a
eukaryotic 59 leader does not preclude the presence of an IRES.
Indeed, it was previously reported that both an IRES and a cryptic
promoter are present in the 59 leader of hepatitis C virus (HCV)
[38]. To more conclusively demonstrate IRES activity in cells, we
transfected cells directly with RNA. This approach should reveal
IRES activity exhibited by mRNA without subjecting it to nuclear
processes. Indeed, aberrant RNA species following transfection of
DNA constructs have not been observed when the corresponding
RNA was transfected [39]. Using RNA transfections, all three
mouse TrkB 59 leaders demonstrated IRES activity. In addition,
the TrkB 59 leaders were able to initiate translation in vitro when
cap-dependent translation was inhibited. Together, these data
suggest that despite the presence of a cryptic promoter, the mouse
TrkB 59 leaders can internally initiate translation.
Multiple IRESes Present in a Single mRNA
The mouse TrkB mRNA is one of only a few eukaryotic
mRNAs to contain two IRESes within the same mRNA.
Transcription of the mouse TrkB gene from promoter 1 yields
the 59 leader 1 with IRESes located within Ex1 and Ex2. The
IRES in Ex1 was further localized to the 59 end, a region that is
within all alternatively spliced variants. The rationale for multiple
IRESes on the same 59 leader is not known. It is possible that
multiple IRESes work cooperatively to increase IRES activity. If
this was occurring with the Ex1a and Ex2 IRESes, we predict the
presence of both IRESes (L1) would generate higher IRES activity
than either IRES alone. However, L1 exhibited a lower P:R ratio
than either Ex1a or Ex2 alone (Fig 4).
A second possibility is that the two IRESes initiate at different
initiator codons. This situation occurs with the two IRESes located
within the c-myc mRNA. The upstream element, IRES 1, initiates
translation of the MYCHEX1 open reading frame (ORF) while
the downstream IRES 2 initiates the c-myc 1/ c-myc 2 ORF [40].
Additionally, two IRESes exist in the 59 leader of the mRNA
coding for endothelial growth factor (VEGF). They control
initiation at two alternative start sites yielding a protein with a
different N-terminus [41,42]. Interestingly, an upstream ORF
(uORF) located between the two IRESes determines which IRES
is utilized [43]. The mouse TrkB Exon 1 contains 15 potential
uORFs that could also regulate the usage of the two TrkB IRESes.
Only one uORF (21048 nt in Ex1b) is in a moderately favorable
Kozak context. It would therefore, be of interest to determine if
the predicted 4.2 kD product encoded in Exon 1 is synthesized.
We cannot identify at present, whether one or both IRESes is
utilized in the full length L1 59 leader. However, since all 59
leaders containing one or two IRESes (regardless of the presence
of uORFs) yield equivalent levels of luciferase protein it indicates
that the major ORF is the Photinus luciferase ORF. This
observation is in agreement with the identification of a single
initiation start site in both the mouse and human TrkB genes
[27,28], and would be the first example of two unique IRESes
being used to produce the identical protein.
A third explanation is that the two IRESes are differentially
employed. Multiple mechanisms may exist to ensure the presence
and/or use of one IRES. For example, neural activity increases
transcription mediated by promoter 2 generating an mRNA with
only one IRES [44]. Second, the presence of RNA upstream of an
IRES may inhibit its function [45]. In this case, the Ex1a IRES
would be active in the full-length leader if the presence of the
upstream sequence inhibits the Ex2 IRES. Finally, when both
IRESes are present, IRES selection may be regulated by the
presence of ITAFs. It has been well documented that IRESes are
neither constitutively nor ubiquitously active. IRESes, including
those in the mouse TrkB 59 leaders, as well as human TrkB [16], c-
IAP1 [46], Apaf-1 [47] and c-myc [48], demonstrate varying
activities in different cell lines, presumably due to differential
expression of ITAFs. Indeed, we have shown that the two IRESes
within the TrkB 59 leader are differentially regulated within a cell
line. This level of regulation is likely functional within primary
neurons. For example, Ex2 IRES is only active in differentiated
SH-SY5Y cells, a model for post-mitotic neurons that are capable
of neural activity [49]. Neural activity in turn promotes the use of
promoter 2 generating a TrkB 59 leader containing only the Ex2
IRES [44]. This observation provides a link between the
differential usage of the TrkB promoters and TrkB translation.
At the molecular level, differential usage of the two TrkB
IRESes may be regulated in part by PTB1. IRES activity in vitro
mediated by the Ex2 IRES was increased in the presence of PTB1.
In addition, Ex2 IRES activity correlates with the expression
pattern of PTB1 within SH-SY5Y cells [9] and is decreased when
PTB1 levels are significantly reduced. IRES activity mediated by
Ex2 mirrors that of the Apaf-1 IRES in that it is also only active in
differentiated SH-SY5Y cells and is regulated by PTB1 [9].
Binding of an accessory protein to an mRNA does not implicate
the protein as an ITAF. In vitro translation assays and RNA
transfections into SH-SY5Y cells demonstrate that although PTB1
binds to both Ex1a and Ex2, it only affects Ex2 IRES activity. Ex1a
does not require PTB1 to internally initiate translation and the
changes in the level of PTB1 does not alter Ex1a IRES activity, an
observation seen previously for one of the IRESes in the VEGF 59
leader [42]. It remains possible that PTB1 plays a role in enhancing
Ex1a IRES activity in conjunction with additional factors that are
absent from RRL and SH-SY5Y cells. The Apaf-1 and BAG-1
IRESes require the presence of unr and poly(rC) binding protein 1
respectively, in addition to PTB1, for IRES activity [5,50].
The position of the PTB1 site within the mRNA secondary
structure can determine whether PTB1 binding can affect IRES
activity. Therefore, the inability of PTB1 to enhance Ex1a IRES
activity may be due to the context of the PTB1 binding sites. The
Willis lab demonstrated that the PTB1 binding site, a CCU repeat,
can only internally initiate translation when present within a stem
structure and not as single stranded RNA [31]. Consequently, it
would be predicted that potential PTB1 binding sites within Ex2
are in a double stranded conformation, while those within Ex1a
would exist in a single stranded state.
It is also possible that PTB1 binding to the TrkB mRNA occurs
to mediate another mRNA processing event. PTB1, in addition to
regulating internal initiation, also affects RNA splicing [37]. Since
Exon 1 is alternatively spliced, it is possible that PTB1 is binding
for that purpose. In addition, the assay was performed in isolation
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compete with PTB1 for the binding sites within TrkB and prevent
the binding of PTB1.
Differential use of the TrkB IRESes may be a mechanism to
regulate protein expression levels. For instance, the selection of
which IRES is utilized will alter the sequence and distance over
which the ribosome must scan, in a similar manner to that
predicted for ribosomes recruited to the cap structure. For
example, a long G/C rich 59 leader will impede ribosomal
scanning and decrease the overall level of protein synthesis [51]. In
the case of TrkB, the distance from the Ex1a IRES is over 1kb
long, is G/C rich, and contains multiple upstream AUGs.
Therefore, when less TrkB is required, initiation could occur
from the Ex1a IRES. However, when TrkB upregulation is
required to affect synaptic plasticity in response to neural activity,
initiation could occur from the shorter, and now more prevalent
Ex2 IRES. Consequently, the presence of multiple IRESes on a
single 59 leader may provide an additional mechanism to regulate
protein synthesis.
Materials and Methods
Constructs
The mouse TrkB 59 leaders (Fig 1a), with the exception of L1,
were cloned from a mouse brain cDNA library (Clontech) with
EcoRI and NcoI restriction sites. L1 was created by PCR
amplifying exon 1 and exon 2 separately. Exon 1 was created
with an EcoRI site at the 59 end and a blunt 39 end. Exon 2 had a
blunt 59 end and an NcoI site at its 39 end. The central blunt ends
were ligated together and the combined exons were the inserted
into the RF vector using the EcoRI and NcoI sites at the insert
ends. The RF vector was a generous gift from Dr. Anne Willis,
University of Nottingham.
In order to create the dual monocistronic vector, the RF
constructs were then digested with EcoRI and HpaI to isolate the
59 leader, the Photinus luciferase gene, and the SV40 39 UTR. This
portion was then ligated into the pGL3 vector (Promega). To isolate
the 59 leader and Photinus luciferase gene from this vector, it was
digested with SnaBI and ApaLI. The fragment was then ligated into
a backbone that already contained a monocistronic Renilla luciferase
gene, creating a vector that contains both luciferase genes in a
monocistronic context. The mono- and dicistronic constructs used
for in vitro transcription were made as described in [16].
To create the promoterless constructs, the b-globin RP vector
was digested sequentially with SmaI and EcoRV to release the
upstream intron and promoter. The blunt ends were then ligated
together to create the promoterless vector. The 59 leaders were
exchanged using the EcoRI and NcoI restriction sites.
DNA containing the cricket paralysis virus (CrPV) IRES was
PCR amplified from plasmid DNA designed as described in [52]
using M13 primers. The original CrPV IRES DNA was a
generous gift from Dr. Peter Sarnow, Stanford University.
Capped RNA used for in vitro translation and RNA transfections
was in vitro transcribed using the mMessage Machine kit (Ambion)
per manufacturer’s instructions as described in [16]. Uncapped
RNA used for in vitro binding assays was in vitro transcribed using
the MEGAScript kit (Ambion) per manufacturer’s instructions.
Cell Culture/Transfections
C6 and N2a cell lines were purchased from ATCC and cultured
in DMEM, 10% fetal bovine serum, and 200 mM L-glutamine.
Two micrograms of DNA was transfected into the cells using
FuGene6 reagent (Roche). The cells were harvested 24 hours later
and lysed using passive cell lysis buffer (Promega). The lysate was
then assayed for luciferase activity using the Dual-Luciferase
Reporter Assay System (Promega) measured using a Luminoskan
luminometer.
Co-transfections were performed as described above using
1.8 mg of RP DNA and 0.2 mg of either the Pactag null vector
(based on pACTAG-2) or DNA encoding for a hypopho-
sphorylated version of 4E-BP1 [33]. The 4E-BP1 and pAC-
TAG-2 constructs were a generous gift from Dr. Nahum
Sonenberg, McGill University.
RNA transfections using 2 mg of RNA were performed using
the RNA Transmessenger kit (Qiagen) per manufacturer’s
instructions. The cells were incubated for seven hours after
transfection, harvested, and assayed for luciferase activity.
SH-SY5Y cells were purchased from ATCC and cultured in
DMEM, 10% fetal bovine serum, and 200 mM L-glutamine. Cells
were plated four days prior to transfection and differentiated by
treating with 2 mM retinoic acid. Upon transfection, the media
was replaced with DMEM. Three hours into the transfection, the
media was exchanged and retinoic acid or the carrier DMSO was
added to the cells for the remainder of the incubation.
PTB1 Purification
Rosetta cells (Novagen) were transformed with the plasmid
PGEX-2TK-PTB1, encoding GST-tagged full-length human
PTB1. The PTB1 construct was a generous gift from M. A.
Garcia-Blanco. Bacteria were grown in 2XYT media to a density
0.35 ODU595nm at which time expression of GST-1 was induced
with 0.2 mM IPTG. After 18 hrs of expression at 25uC, the cells
were collected by centrifugation and resuspended in lysis buffer
(50 mM Tris-HCl pH 8.0, 0.25 M NaCl, 1 mM TCEP, 1 mM
EDTA). After lysis by sonication, the NaCl concentration was
raised to 1 M and the lysate clarified by centrifugation. The
resulting supernatant was applied to glutathione-coupled agarose
(GE-Healthcare), and the column was washed with lysis buffer to
remove the excess NaCl. To liberate PTB1, thrombin was added
and the column was incubated at 25uC for 3 hours with gentle
agitation followed by elution of the PTB1. Glycerol was added to
the PTB1 containing fractions to a final concentration of ,10%
(v/v). Afterwards, the fractions were concentrated. The PTB1 was
further purified by size exclusion chromatography on a Sup200
column (GE Healthcare) in lysis buffer. To remove any bound
nucleic acids from PTB1, the protein was bound to a heparin
column (GE Healthcare) in lysis buffer, and eluted with a 0.25–
2 M NaCl linear gradient. The PTB1 containing fractions were
concentrated, dialyzed against the storage buffer (50 mM Tris-
HCl pH 8.0, 0.25 M NaCl, 1 mM TCEP, 1 mM EDTA, 20%
glycerol (v/v)), and stored at 4uC.
In Vitro Translation
One microgram of Photinus luciferase monocistronic mRNA was
added to rabbit reticulosyte lysate (RRL) (Red Nova, Novagen) in
the presence of cap analog (Ambion). Following a 1 hour
incubation at 30uC, the sample was assayed for Photinus luciferase
activity.
For the in vitro translation assays involving PTB1, 1 mgo f
dicistronic mRNA was added to RRL (Promega) in the presence of
0.4 mg of PTB1 protein. The lysates were incubated for 1 hour at
30uC and then the samples were assayed for luciferase activity as
described above.
PTB1 Binding Assay
Approximately 2 pmol of radiolabeled RNA (500 cpm) was
combined with increasing amounts of recombinant PTB1 protein
in protein binding buffer (10 mM Tris-HCl pH 8, 100 mM KCl,
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was incubated for 10 minutes at 37uC and then passed through a
dot blot apparatus containing a sandwich of nitrocellulose and
charged nylon membranes. A ratio of the fraction of bound RNA
to the total RNA was calculated and plotted against the PTB1
concentration. The curve was fit using the Langmuir formula
[(m0*m1/(M0+m2)+m3);m1=.9;m2=1e29;m3=.001] to deter-
mine the dissociation constant.
siRNA Transfection
SH-SY5Y cells were treated for two days with either DMSO
(mock) or 2 mM retinoic acid to induce differentiation. The cells
were incubated with 300 mM siRNA (Dharmacon) and Dharma-
fect 1 reagent (Dharmacon). After 24 hours, the siRNA and media
were aspirated off and fresh media was applied to the cells for an
additional 24 hours. The cells were treated with DMSO or 2 mM
retinoic acid for an additional 48 hours. At this stage, the cells
were either harvested for Western blot analysis or transfected with
RNA as described above.
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